发明名称 |
METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN |
摘要 |
The present invention is directed to methods and compositions for treating pulmonary disease comprising delivering directly to a patient's lungs a therapeutically effective amount of oxybutynin in combination with one or more pharmaceutically effective agents. Oxybutynin may be selected from the group consisting of, but not limited to, a xinafoate salt, a palmitate salt, a pamoic salt, a resonate salt, a laurate salt and other salts. The pharmaceutically effective agents comprise bronchodilators, antiinflammatories, corticosteroids, corticosteroid reversal agent or alveolar growth agents or other agents selected from proteinase or protease inhibitors. |
申请公布号 |
US2015238456(A1) |
申请公布日期 |
2015.08.27 |
申请号 |
US201514707787 |
申请日期 |
2015.05.08 |
申请人 |
MICRODOSE THERAPEUTX, INC. |
发明人 |
Cook Robert;Byron David A.;Fleming Scott |
分类号 |
A61K31/216;A61K31/167;A61M15/00;A61K9/00;A61M11/00;A61K45/06;A61K9/14 |
主分类号 |
A61K31/216 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating pulmonary disease comprising delivering directly to a patient's lungs a therapeutically effective amount of oxybutynin in combination with one or more pharmaceutically effective agents, wherein the oxybutynin is selected from the group consisting of a palmitate salt, a pamoic salt, and a resonate salt. |
地址 |
Monmouth Junction NJ US |